β-Adrenergic receptor blockade impairs coronary exercise hyperemia in young men but not older men.
β-Adrenergic receptor blockade impairs coronary exercise hyperemia in young men but not older men.
复制标题
β-肾上腺素能受体阻断会损害年轻男性的冠状动脉运动充血,但不会损害老年男性。
DOI:
10.1152/ajpheart.00584.2014
复制
发表时间:
2014
期刊:
影响因子:
--
通讯作者:
Muller,MatthewD
中科院分区:
文献类型:
--
作者:
Ross,AmandaJ;Gao,Zhaohui;Pollock,JonathanP;Leuenberger,UrsA;Sinoway,LawrenceI;Muller,MatthewD
Patients with coronary artery disease have attenuated coronary vasodilator responses to physiological stress, which is partially attributed to a β-adrenergic receptor (β-AR)-mediated mechanisms. Whether β-ARs contribute to impaired coronary vasodilation seen with healthy aging is unknown. The purpose of this study was to investigate the role of β-ARs in coronary exercise hyperemia in healthy humans. Six young men (26 ± 1 yr) and seven older men (67 ± 4 yr) performed isometric handgrip exercise at 30% maximal voluntary contraction for 2 min after receiving intravenous propranolol, a β-AR antagonist, and no treatment. Isoproterenol, a β-AR agonist, was infused to confirm the β-AR blockade. Blood pressure and heart rate were monitored continuously, and coronary blood flow velocity (CBV, left anterior descending artery) was measured by transthoracic Doppler echocardiography. Older men had an attenuated ΔCBV to isometric exercise (3.8 ± 1.3 vs. 9.7 ± 2.1 cm/s,P= 0.02) compared with young men. Propranolol decreased the ΔCBV at peak handgrip exercise in young men (9.7 ± 2.1 vs. 2.7 ± 0.9 cm/s,P= 0.008). However, propranolol had no effect on ΔCBV in older men (3.8 ± 1.3 vs. 4.2 ± 1.9 cm/s,P= 0.9). Older men also had attenuated coronary hyperemia to low-dose isoproterenol. These data indicate that β-AR control of coronary blood flow is impaired in healthy older men.
登录
查看更多内容
DOI:
10.1096/fasebj.26.1_supplement.864.15
发表时间:
2012
期刊:
The FASEB Journal
影响因子:
--
作者:
Zhaohui Gao;R. Drew;A. Momen;I. Ndukwu;M. Muller;J. Mast;Cheryl A. Blaha;U. Leuenberger;L. Sinoway
通讯作者:
L. Sinoway
影响因子:
37.8
作者:
Go AS;Mozaffarian D;Roger VL;Benjamin EJ;Berry JD;Blaha MJ;Dai S;Ford ES;Fox CS;Franco S;Fullerton HJ;Gillespie C;Hailpern SM;Heit JA;Howard VJ;Huffman MD;Judd SE;Kissela BM;Kittner SJ;Lackland DT;Lichtman JH;Lisabeth LD;Mackey RH;Magid DJ;Marcus GM;Marelli A;Matchar DB;McGuire DK;Mohler ER 3rd;Moy CS;Mussolino ME;Neumar RW;Nichol G;Pandey DK;Paynter NP;Reeves MJ;Sorlie PD;Stein J;Towfighi A;Turan TN;Virani SS;Wong ND;Woo D;Turner MB;American Heart Association Statistics Committee and Stroke Statistics Subcommittee
通讯作者:
American Heart Association Statistics Committee and Stroke Statistics Subcommittee
影响因子:
3.5
作者:
H. Pan;B. Hoffman;R. Pershe;T. Blaschke
通讯作者:
T. Blaschke
影响因子:
8.3
作者:
Cardillo, C;Kilcoyne, CM;Panza, JA
通讯作者:
Panza, JA
影响因子:
3
作者:
Gao, Zhaohui;Spilk, Samson;Momen, Afsana;Muller, Matthew D.;Leuenberger, Urs A.;Sinoway, Lawrence I.
通讯作者:
Sinoway, Lawrence I.